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Abstract
Background:  Gastrointestinal stromal tumors are rare visceral sarcomas arising in the
gastrointestinal tract wall. In this report we present a case of gastrointestinal stromal tumors with
mesenteric and retroperitoneal invasion, describe and discuss its computed tomography findings.
Case presentation: A 57-years-old male patient has been complaining of abdominal distention,
weight lose, and hematuria. During physical examination, significant distention and multiple palpable
tumor masses were identified on the abdomen. Abdominal computed tomography showed
multiple, well-defined, soft tissue masses with homogenous and heterogeneous pattern, in the
mesenteric and retroperitoneal areas. Unlike specific features of gastrointestinal stromal tumor,
renal obstruction and atypical central calcification without chemotherapy that has not been yet
described were seen in this case. Computed tomography did not reveal liver metastases and/or the
lymph nodes with pathological size. Ultrasonography-guided true-cut®  biopsy was made,
histopathologic and immunohistochemical analyses demonstrated stromal tumor which, C-KIT (+).
The patient underwent left ureterectomy, left nephrectomy and total colectomy. Postoperative
histopathological analyses revealed lower grade malignant GISTs. As of 17 months after the
surgery, he is alive and free of recurrence.
Conclusion: When intraabdominal, multiple, large (>5 cm), well-circumscribed, homogenous or
heterogeneous mass lesions without ascites, omental caking and lymph nodes metasteses were
seen, gastrointestinal stromal tumors should be considered in the differential diagnosis.
Background
Gastrointestinal (GI) stromal tumor (GIST) is a rare vis-
ceral sarcoma arising in the gastrointestinal tract wall
[1,2]. This tumor arises in the muscularis mucosa and
muscularis propria layers anywhere from the esophagus
to the rectum. Its most common anatomic sites of origin
are the stomach (60–70%), small intestine (20–30%),
colon and rectum (5%), abdominal cavity, i.e. perito-
neum and omentum (5%), esophagus (<5%) and retro-
peritoenal space (<3%) [3-5] In this report we present a
rare case of multiple primary mesenteric and retroperito-
neal GISTs, describe and discuss its computed tomogra-
phy (CT) findings.
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Case presentation
A 57-years-old male patient was admitted to the general
surgery department with abdominal distention, weight
loss and hematuria. During physical examination, signifi-
cant distention and multiple palpable tumor masses were
identified on the abdomen (Figure 1). Contrast-enhanced
abdominal multi detector CT imaging was performed
with a four-detector row CT scanner (Somatom Sensation
4®, Siemens Medical Solutions, Erlangen, Germany). Mul-
tiple, well-defined, soft tissue masses with homogenous
pattern, measuring maximum 6 × 5 cm in size were
observed in the mesenteric and retroperitoneal areas (Fig-
ure 2, 3). In some masses, central necrosis and coarse cal-
cifications were seen (Figure 4). There was grade 3
hydronephrosis in the left kidney due to the left ureteric
invasion (Figure 2, 3, &4). However, CT did not reveal
liver metastasis and/or the lymph nodes with pathological
size.
Ultrasonography (US)-guided true-cut® biopsy was made,
histopathologic (Figure 5, 6) and immunohistochemical
analyses demonstrated stromal tumor which, C-KIT
(+)(Figure 7), CD34 (-), S-100 (-), desmin (-), actine (-)
Ki-67 (+)(Figure 8) and with a proliferation index of <%1.
During the operation, not only the tumor filling the
whole abdomen but masses invading small bowel mesen-
tery, left hemicolon and the left ureter have been detected.
The patient underwent left ureterectomy, left nephrec-
tomy and total colectomy. Proximally from the treitz,
small bowel resection from a distance of 200 cm was
applied. The mass have been totally removed and taken
out of the abdomen (Figure 9). The operation has been
completed with an end-ileostomy (Figure 10).
Postoperative histopathological analyses revealed that the
tumor was total 25 cm in diameter. It was composed of
spindle-shaped cells with hemorrhagic areas. Mitotic
Abdominal CT image of slightly more distal of figure 2 shows  multiple, mesenteric (white small arrows) and retroperito- neal (black arrows), well-defined, homogenous, solid masses Figure 3
Abdominal CT image of slightly more distal of figure 2 shows 
multiple, mesenteric (white small arrows) and retroperito-
neal (black arrows), well-defined, homogenous, solid masses. 
There is also grade 3 hydronephrosis in the left kidney (white 
arrowhead)
Preoperative appearance of the patient showing abdominal  distention Figure 1
Preoperative appearance of the patient showing abdominal 
distention.
Abdominal CT image shows homogenous, well-defined, mass  lesion in the retroepritoneal area (black arrows) Figure 2
Abdominal CT image shows homogenous, well-defined, mass 
lesion in the retroepritoneal area (black arrows). Grade 3 
hydronephrosis in the left kidney is shown with white arrow-
head.World Journal of Surgical Oncology 2007, 5:121 http://www.wjso.com/content/5/1/121
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activity was 3 mitoses per 50 HPF. The tumor invaded the
small bowel serosa, colonic submucosa and the left ureter.
Thus the tumor was not described as an extra-GIST that
arose from the soft tissue of the abdominal cavity (omen-
tum and mesentery) and retroperitoneum because of the
existance of an attachment of serosa of GI tract [4]. The
tumor was described as a GIST with predominant
mesenteric and retroperitoneal invasion and classified as
a lower grade GIST according to Bucher grading system for
GIST after surgical resection [6].
He had an uneventful postoperative course and was dis-
charged home on postoperative day 3. As of 17 months
after the surgery, he is alive and free of recurrence.
In microscopic appearance of immunohistochemical analyses,  CD117   immunoreactivity is shown as diffuse strong cyto- plasmic staining in spindle   cell (CD117 immunostain,  W200).  Figure 7
In microscopic appearance of immunohistochemical analyses, 
CD117   immunoreactivity is shown as diffuse strong cyto-
plasmic staining in spindle   cell (CD117 immunostain, 
W200). 
In microscopic appearances of histopathologic analyses, GIST  has spindle cell phenotype in a storiform array.   Figure 5
In microscopic appearance of histopathologic analyses, GIST 
has spindle cell phenotype in a storiform array. Note the 
compact and highly   cellular pattern, mild-diffuse atypia 
(H&E, W100). 
Abdominal CT image of slightly more distal of figure 3 shows  multiple, homogenous or central necrotic (black arrows) or  calcific (white arrow) masses invaded to the small bowel  mesentery and left ureter (arrowhead) Figure 4
Abdominal CT image of slightly more distal of figure 3 shows 
multiple, homogenous or central necrotic (black arrows) or 
calcific (white arrow) masses invaded to the small bowel 
mesentery and left ureter (arrowhead).
In microscopic appearance of histopathologic analyses, GIST  cells   have paler eosinophilic cytoplasm with indistinct cell  margins and minimal   tumor stroma  (H&E, W200). Figure 6
In microscopic appearance of histopathologic analyses, GIST 
cells   have paler eosinophilic cytoplasm with indistinct cell 
margins and minimal   tumor stroma  (H&E, W200). World Journal of Surgical Oncology 2007, 5:121 http://www.wjso.com/content/5/1/121
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Discussion
CT, magnetic resonance imaging (MRI) and fluorine-18-
fluorodeoxyglucose (FDG) positron emission tomogra-
phy (PET) can be used for evaluation of GIST. Contrast-
enhanced CT scan is, however, more widely available and
is currently the imaging modality of choice for patients
with suspected abdominal mass or biopsy-proven GIST.
CT is used in staging and surgical planning. When a small
tumor is found incidentally during endoscopy, the local
extent of the tumor should be evaluated using either
endoscopic ultrasound or CT. For those with known or
suspected rectal GIST, a dedicated MRI provides better
information than CT scan in preoperative staging work-
up. Evaluation of FDG uptake using PET scanning is rec-
ommended when an early detection of tumor response to
imatinib treatment is required [7].
CT findings of GISTs are well described in the radiological
literature [8-13]. Malignant GISTs are typically extralumi-
nal, large (>5 cm), well-circumscribed, heterogeneous,
centrally necrotic tumors. Such features contrast with the
regular contours, homogeneous density, and intraluminal
growth patterns that are characteristic of smaller benign
GISTs. Thus, well-circumscribed tumors appear to be a
feature of GISTs, as in our case, on CT imaging. Heteroge-
neous density, on the other hand, was independent from
tumor dimension. Heterogeneous density, pathologically
concordant with hemorrhage, has been found in tumors
less than 5 cm, despite the homogeneous densities found
in the tumors bigger than 5 cm.
Exceptional to the reports published so far, Takao et al.,
reported a GIST of the peripancreatic retroperitoneum
with CT and MR imaging findings representing huge well-
defined inhomogeneous mass with peripheral calcifica-
tion [14]. In our case, atypical central course calcification
without chemotherapy that has not been yet described,
were seen in only one mass.
The spread pattern of these tumors shows predilection for
liver metastasis and peritoneal dissemination [14]. In that
case, however, concordant with the results of a few studies
published previously, the relationship between multiple
tumors and metastasis was not seen. No liver or lymph
node metastasies have been seen in spite of multiple
malign stromal tumor masses [5,11].
Postoperative appearance of the patient Figure 10
Postoperative appearance of the patient. Abdominal disten-
sion has been significantly reduced after the masses have 
been totally removed. Incision scar and an end ileostomy bag 
are seen.
Microscopic appearances of immunohistochemical analyses Figure 8
Microscopic appearances of immunohistochemical analyses. 
Approximately 15% of tumor cells show nuclear positivity for 
Ki-67 (MIB-1) (arrows) (Ki-67 immunostain, ×200).
Multiple tumoral nodules in colon serosa and mesocolon are  shown in gross specimen after performing total colectomy Figure 9
Multiple tumoral nodules in colon serosa and mesocolon are 
shown in gross specimen after performing total colectomy.World Journal of Surgical Oncology 2007, 5:121 http://www.wjso.com/content/5/1/121
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Burkill et al., reported that stromal tumors rarely obstruct
viscera, despite their large size [10]. In our case, no small
bowel or colonic obstruction findings have been found in
spite of the proximity of mesenteric multiple mass lesions
to the colon, – especially descending colon-. However, in
that case, there is a hydronephrosis due to ureteral
obstruction which is a very rare finding. In the report of
Burkill et al., 116 malignant GIST were analyzed, and only
one case has this behavior [10].
In our case, we have seen multiple peritoneal tumor
masses without peritoneal fluid. Burkill, et al., concord-
antly with our case, reported that ascites and omental cak-
ing were unusual findings in stromal tumors [10].
Tumor size, anatomic location, and mitotic count are con-
sidered independent prognostic factors for GISTs [15,16],
and tumors that measure ≥5 cm are associated with an
unfavorable prognosis. The anatomic site of origin of a
GIST is associated strongly with its clinical behavior, and
patients who have tumors that arise in the rectum or small
intestine have the worst prognosis compared with the
more favorable outcomes observed among patients who
have esophageal and gastric neoplasms [16]. Likewise,
GISTs that exhibit ≥5 mitoses per 50 HPF or ≥2 mitotic fig-
ures per 10 HPF are associated with an unfavorable prog-
nosis regardless of their site of origin [15,17-22]. Our case
had multiple mesenteric and retroperitoneal stromal
tumors; mitoses were < 5 per 50 HDI, total tumor diame-
ter was 25 cm. The localization was unfavorable but bad
prognostic signs such as liver or lymph node metastases
were not seen.
The differential diagnosis of an abdominal mass with well
defined, extraluminal masses and homogeneous enhance-
ment in the abdominal cavity includes peritoneal
implants, lymphoma, primary peritoneal carcinomatosis,
carcinoids, and other soft-tissue tumors (leiomyosar-
coma, malignant tumors of nerve sheath and vascular ori-
gin) [10,12,23]. In our case, absence of peritoneal ascites
and omental caking excluded peritoneal implant and pri-
mary peritoneal carcinomatosis, absence of lymph node
metastases excluded lymphoma diagnosis. For definitive
diagnosis, US-guided true-cut®  biopsy and then his-
topathologic and immunohistochemical analyses were
made. However, preoperative percutaneous biopsy carries
a theoretical risk of peritoneal seeding or tumor rupture,
and is indicated only for clearly irresectable disease or
when treatment needs to be altered, as would be the case
if the mass proved to be lymphoma or germ cell tumor
[24]. One alternative technique is endoscopic US-fine
needle aspiration (FNA), which has been used increas-
ingly for the evaluation of different types of intraabdomi-
nal and intrathoracic lesions. Observations to date
indicate that endoscopic US-FNA is a safe and accurate
procedure [25].
Immunoreactivity for CD117 (C-KIT) is a characteristic of
GISTs; in addition, most GISTs express CD34 immunos-
tain. Another marker that is considered useful in the
assessment of GISTs is Ki-67 immunostain, with reported
100% specificity and sensitivity for malignancy on GISTs
[26]. Immunohistochemical studies on that tumor cells
revealed positive staining for C-KIT (CD117), whereas
CD34, antibodies against smooth-muscle actin (SMA),
desmin, actine and S-100 protein were negative.
Conclusion
When intraabdominal, multiple, large (>5 cm), well-cir-
cumscribed, homogenous or heterogeneous mass lesions
without ascites, omental caking and lymph nodes
metasteses were seen, GIST should be considered in the
differential diagnosis.
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